270 Rue de Neudorf
Grand Duchy of Luxembourg
+352 28 26 1100
C2 Pharma is a Luxembourg-based pharmaceutical group established in 2014 that manufactures and distributes its active pharmaceutical ingredients (APls) and complex chemical compounds from phytochemical and chemical origins
C2 PHARMA is a Luxembourg-based pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds obtained from natural and synthetic origins.
The current API product portfolio includes atropine, digoxin, homatropine, pilocarpine, and N-butylbromide scopolamine/hyoscine (SNBB), and reaches more than 100 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, Middle-East and Africa.
We are a key sponsor of the “Partnerships for a Better World” program that ensures sustainable, traceable and fair-trade harvesting and sourcing of raw materials for the manufacturing of APIs, such as pilocarpine. The program sustains more than 1,000 families and contributes to the preservation of Brazilian biodiversity.
C2 PHARMA also offers customized cold-chain logistics solutions through its specialized affiliate Logistics4Pharma (logistics4pharma.com), as well as R&D-scale contract synthesis services, analytical services, phytochemical profiling and impurities manufacturing through its affiliate ASM Research Chemicals (www.asm-research-chemicals.de).
C2 PHARMA is specialized in the manufacturing and distribution of APIs with a direct sales presence across approximately 100 direct customers around the globe, including the top big pharma companies.
C2 PHARMA can assist pharmaceutical companies streamline their product portfolio by acquiring and/or managing their APIs and drug products which may be non-core, below critical mass, difficult to manufacture or challenging to distribute.
C2 PHARMA offers customized cold chain and fully-GDP compliant transport and storage solutions through its specialized affiliate Logistics4Pharma.
C2 PHARMA offers R&D-scale (non-GMP) contract synthesis services, analytical services, phytochemical profiling and impurities manufacturing through its affiliate ASM Research Chemicals.